Opinion/decision on a Paediatric investigation plan (PIP): Zejula, niraparib (tosilate monohydrate), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neoplasms benign, malignant and unspecified (incl cyst

Opinion/decision on a Paediatric investigation plan (PIP): Zejula, niraparib (tosilate monohydrate), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0229/2024